Hansa Biopharma reports Q4 results
Source: SeekingAlpha
2026-02-11 05:05:23 ET
More on Hansa Biopharma
- Hansa Biopharma AB (publ) (HNSBF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Hansa Biopharma
- Historical earnings data for Hansa Biopharma
- Financial information for Hansa Biopharma
Read the full article on Seeking Alpha
For further details see:
Hansa Biopharma reports Q4 results
Hansa Biopharma AB
NASDAQ: HNSBF
HNSBF Trading
-85.0% G/L:
$2.91 Last:
28,750 Volume:
$2.91 Open:
HNSBF Latest News
September 24, 2025 02:06:00 pm
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
